
Access to common abortion bills in the US plunged into uncertainty after conflicting court rulings were issued over the legality of medication widely available for more than 20 years.
Abortion medication mifepristone - approved by the Food and Drug Administration (FDA) in 2000 - was blocked Donald Trump appointee US District Judge Matthew Kacsmaryk, who ordered a hold on federal approval of mifepristone in Texas as part of a decision that overruled decades of scientific approval.